Roivant Sciences (ROIV) Cash from Operations (2020 - 2026)

Roivant Sciences (ROIV) has 6 years of Cash from Operations data on file, last reported at 586531000.0 in Q4 2025.

• Quarterly Cash from Operations rose 12.05% year-over-year to 586531000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 1643464000.0 (up 7.84% YoY) and the FY2026 annual result came in at 750349000.0, up 10.61% from the prior year.
• Cash from Operations retreated to 586531000.0 in Q4 2025, from 185664000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 120596000.0 in Q3 2021 to a low of 666886000.0 in Q4 2024.
• A 5-year average of 340287466.67 and a median of 249932000.0 in 2023 frame the typical range for Cash from Operations.
• Annual changes were most pronounced in 2021 — Cash from Operations plunged 187.71% — and 2025, when it jumped 30.41%.
• Tracing ROIV's Cash from Operations over 5 years: stood at 530260000.0 in 2021, then declined by 25.28% to 664305000.0 in 2022, then gained by 1.13% to 656811000.0 in 2023, then declined by 1.53% to 666886000.0 in 2024, then rose by 12.05% to 586531000.0 in 2025.
• The last three Cash from Operations figures came in at 586531000.0 (Q4 2025), 185664000.0 (Q3 2025), and 204383000.0 (Q2 2025), per Business Quant data.